|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tsiaoussis J, Vassilopoulou L,
Nikolouzakis T, Rakitskii VN, Vakonaki E, Fragkiadaki P,
Stivaktakis P and Tsatsakis AM: Biomolecular profile of colorectal
cancer - The role of telomerase as a potent biomarker. Farmacia.
65:643–659. 2017.
|
|
3
|
Nikolouzakis TK, Vassilopoulou L,
Fragkiadaki P, Mariolis Sapsakos T, Papadakis GZ, Spandidos DA,
Tsatsakis AM and Tsiaoussis J: Improving diagnosis, prognosis and
prediction by using biomarkers in CRC patients (Review). Oncol Rep.
39:2455–2472. 2018.PubMed/NCBI
|
|
4
|
Cunningham D, Atkin W, Lenz HJ, Lynch HT,
Minsky B, Nordlinger B and Starling N: Colorectal cancer. Lancet.
375:1030–1047. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Engstrand J, Nilsson H, Strömberg C, Jonas
E and Freedman J: Colorectal cancer liver metastases - a
population-based study on incidence, management and survival. BMC
Cancer. 18:782018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Souglakos J, Philips J, Wang R, Marwah S,
Silver M, Tzardi M, Silver J, Ogino S, Hooshmand S, Kwak E, et al:
Prognostic and predictive value of common mutations for treatment
response and survival in patients with metastatic colorectal
cancer. Br J Cancer. 101:465–472. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Richman S and Adlard J: Left and right
sided large bowel cancer. BMJ. 324:931–932. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Haggar FA and Boushey RP: Colorectal
cancer epidemiology: Incidence, mortality, survival, and risk
factors. Clin Colon Rectal Surg. 22:191–197. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Koliarakis I, Psaroulaki A, Nikolouzakis
TK, Sgantzos M, Kokkinakis M, Goulielmos G, Androutsopoulos V,
Tsatsakis A and Tsiaoussis J: Intestinal microbiota and colorectal
cancer: A new aspect of research. J BUON. 23:1216–1234.
2018.PubMed/NCBI
|
|
10
|
Adam R, de Gramont A, Figueras J, Kokudo
N, Kunstlinger F, Loyer E, Poston G, Rougier P, Rubbia-Brandt L,
Sobrero A, et al of the EGOSLIM (Expert Group on OncoSurgery
management of LIver Metastases) group, : Managing synchronous liver
metastases from colorectal cancer: A multidisciplinary
international consensus. Cancer Treat Rev. 41:729–741. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RG, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Charlton ME, Kahl AR, Greenbaum AA,
Karlitz JJ, Lin C, Lynch CF and Chen VW: KRAS testing, tumor
location, and survival in patients with stage IV colorectal cancer:
SEER 2010–2013. J Natl Compr Canc Netw. 15:1484–1493. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fenech M, Kirsch-Volders M, Natarajan AT,
Surralles J, Crott JW, Parry J, Norppa H, Eastmond DA, Tucker JD
and Thomas P: Molecular mechanisms of micronucleus, nucleoplasmic
bridge and nuclear bud formation in mammalian and human cells.
Mutagenesis. 26:125–132. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mateuca R, Lombaert N, Aka PV, Decordier I
and Kirsch-Volders M: Chromosomal changes: Induction, detection
methods and applicability in human biomonitoring. Biochimie.
88:1515–1531. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pardini B, Viberti C, Naccarati A, Allione
A, Oderda M, Critelli R, Preto M, Zijno A, Cucchiarale G, Gontero
P, et al: Increased micronucleus frequency in peripheral blood
lymphocytes predicts the risk of bladder cancer. Br J Cancer.
116:202–210. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ravegnini G, Zolezzi Moraga JM, Maffei F,
Musti M, Zenesini C, Simeon V, Sammarini G, Festi D, Hrelia P and
Angelini S: Simultaneous analysis of SEPT9 promoter methylation
status, micronuclei frequency, and folate-related gene
polymorphisms: The potential for a novel blood-based colorectal
cancer biomarker. Int J Mol Sci. 16:28486–28497. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Maffei F, Zolezzi Moraga JM, Angelini S,
Zenesini C, Musti M, Festi D, Cantelli-Forti G and Hrelia P:
Micronucleus frequency in human peripheral blood lymphocytes as a
biomarker for the early detection of colorectal cancer risk.
Mutagenesis. 29:221–225. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Espinoza F, Cecchini L, Morote J, Marcos R
and Pastor S: Micronuclei frequency in urothelial cells of bladder
cancer patients, as a biomarker of prognosis. Environ Mol Mutagen.
Oct 4–2018.(Epub ahead of print). doi: 10.1002/em.22252. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang RC, Yang L, Tang Y and Bai O:
Micronucleus expression and acute leukemia prognosis. Asian Pac J
Cancer Prev. 14:5257–5261. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dervenis C, Xynos E, Sotiropoulos G,
Gouvas N, Boukovinas I, Agalianos C, Androulakis N, Athanasiadis A,
Christodoulou C, Chrysou E, et al: Clinical practice guidelines for
the management of metastatic colorectal cancer: A consensus
statement of the Hellenic Society of Medical Oncologists (HeSMO).
Ann Gastroenterol. 29:390–416. 2016.PubMed/NCBI
|
|
21
|
Schwartz LH, Litière S, de Vries E, Ford
R, Gwyther S, Mandrekar S, Shankar L, Bogaerts J, Chen A, Dancey J,
et al: RECIST 1.1-Update and clarification: From the RECIST
committee. Eur J Cancer. 62:132–137. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hayashi M: The micronucleus test-most
widely used in vivo genotoxicity test. Genes Environ. 38:182016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stivaktakis P, Vlastos D, Giannakopoulos E
and Matthopoulos DP: Differential micronuclei induction in human
lymphocyte cultures by imidacloprid in the presence of potassium
nitrate. ScientificWorldJournal. 10:80–89. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fenech M: The cytokinesis-block
micronucleus technique: A detailed description of the method and
its application to genotoxicity studies in human populations. Mutat
Res. 285:35–44. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fenech M, Chang WP, Kirsch-Volders M,
Holland N, Bonassi S and Zeiger E: HUman MicronNucleus project:
HUMN project: Detailed description of the scoring criteria for the
cytokinesis-block micronucleus assay using isolated human
lymphocyte cultures. Mutat Res. 534:65–75. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Surrallés J, Xamena N, Creus A, Catalán J,
Norppa H and Marcos R: Induction of micronuclei by five pyrethroid
insecticides in whole-blood and isolated human lymphocyte cultures.
Mutat Res. 341:169–184. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Stivaktakis PD, Giannakopoulos E, Vlastos
D and Matthopoulos DP: Determination of genotoxic effects of
methidathion alkaline hydrolysis in human lymphocytes using the
micronucleus assay and square-wave voltammetry.
Bioelectrochemistry. 113:9–14. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang CZ, Spektor A, Cornils H, Francis
JM, Jackson EK, Liu S, Meyerson M and Pellman D: Chromothripsis
from DNA damage in micronuclei. Nature. 522:179–184. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bonassi S, Znaor A, Ceppi M, Lando C,
Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Ban S, Barale R,
et al: An increased micronucleus frequency in peripheral blood
lymphocytes predicts the risk of cancer in humans. Carcinogenesis.
28:625–631. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schmid W: The micronucleus test. Mutat
Res. 31:9–15. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fenech M and Bonassi S: The effect of age,
gender, diet and lifestyle on DNA damage measured using
micronucleus frequency in human peripheral blood lymphocytes.
Mutagenesis. 26:43–49. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Andreassi MG, Barale R, Iozzo P and Picano
E: The association of micronucleus frequency with obesity, diabetes
and cardiovascular disease. Mutagenesis. 26:77–83. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bonassi S, Coskun E, Ceppi M, Lando C,
Bolognesi C, Burgaz S, Holland N, Kirsh-Volders M, Knasmueller S,
Zeiger E, et al: The HUman MicroNucleus project on eXfoLiated
buccal cells (HUMN(XL)): The role of life-style, host factors,
occupational exposures, health status, and assay protocol. Mutat
Res. 728:88–97. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ramesh G, Chaubey S, Raj A, Seth RK,
Katiyar A and Kumar A: Micronuclei assay in exfoliated buccal cells
of radiation treated oral cancer patients. J Exp Ther Oncol.
12:121–128. 2017.PubMed/NCBI
|
|
35
|
Scaglione F and Panzavolta G: Folate,
folic acid and 5-methyltetrahydrofolate are not the same thing.
Xenobiotica. 44:480–488. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
de Souza AP, Lehmann M and Dihl RR:
Comparative study on the induction of complex genomic alterations
after exposure of mammalian cells to carboplatin and oxaliplatin.
Drug Chem Toxicol. 40:410–415. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kopjar N, Zeljezić D, Vrdoljak AL, Radić
B, Ramić S, Milić M, Gamulin M, Pavlica V and Fucić A: Irinotecan
toxicity to human blood cells in vitro: Relationship between
various biomarkers. Basic Clin Pharmacol Toxicol. 100:403–413.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kasuba V, Rozgaj R, Gamulin M and Trosić
I: Assessment of cyto/genotoxicity of irinotecan in v79 cells using
the comet, micronucleus, and chromosome aberration assay. Arh Hig
Rada Toksikol. 61:1–9. 2010. View Article : Google Scholar : PubMed/NCBI
|
